| DC11768 |
TAM-16 |
A benzofuran class inhibitor of M. tuberculosis Pks13 (Polyketide Synthase 13). |
|
| DC11534 |
Sudoterb
Featured
|
A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL.. |
|
| DC11535 |
Sudoterb dihydrchloride |
A novel anti-TB agent that has an MIC range of 0.06-0.5 ug/mL.. |
|
| DC10513 |
AFN-1252(Debio 1452)
Featured
|
AFN-1252(Debio 1452) is a potent inhibitor of enoyl-acyl carrier protein reductase (FabI), inhibited all clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis at concentrations of ≤0.12 μg/ml. |
|
| DC9827 |
AN3365(Epetraborole)
Featured
|
AN3365 is a first-in-class antibiotic that demonstrates potent activity across a wide spectrum of Gram-negative bacteria, including those resistant to many other antibiotics. |
|
| DC10552 |
AU1235
Featured
|
AU1235 is an adamantyl urea inhibitor of Mycobacterium tuberculosis. |
|
| DCAPI1362 |
Azithromycin (Zithromax) |
Azithromycin (Zithromax) |
|
| DC8809 |
Bedaquiline fumarate
Featured
|
Bedaquiline fumarate(TMC207; R207910) is an anti-tuberculosis drug which selectively inhibit the mycobacterial energy metabolism i.e. ATP synthesis and found to be effective against all states of Mycobacterium tuberculosis. |
|
| DC4143 |
Besifloxacin HCl
Featured
|
Besifloxacin HCl is a fourth-generation fluoroquinolone antibiotic. |
|
| DC10393 |
Bicyclomycin benzoate |
Bicyclomycin benzoate is an antibiotic exhibiting activity against a broad spectrum of Gram-negative bacteria and against the Gram-positive bacterium. |
|
| DC9853 |
BM212
Featured
|
BM-212 is a potent antimycobacterial agent and MmpL3 inhibitor. |
|
| DCAPI1024 |
Cefditoren pivoxil |
Cefditoren pivoxil |
|
| DC8937 |
Clarithromycin |
Clarithromycin is a macrolide antibiotic and a CYP3A4 inhibitor. |
|
| DC11061 |
ClpP inhibitor M21 |
ClpP inhibitor M21 is a noncompetitive inhibitor of ClpP with IC50 of 41.42 uM, inhibits ClpP cleavage of SUc-LY-AMC substrate in a peptidase assay. |
|
| DCAPI1493 |
Dalbavacin
Featured
|
Dalbavancin, a semisynthetic lipoglycopeptide being developed for the treatment of skin and skin structure infections (SSSIs), has a half-life of 5 to 7 days in humans and offers promise for a convenient weekly dosing regimen. |
|
| DC7764 |
Delamanid (OPC-67683)
Featured
|
Delamanid (OPC-67683) is an experimental drug for the treatment of multi-drug-resistant tuberculosis. |
|
| DC10612 |
Delpazolid (LCB01-0371)
Featured
|
Delpazolid (LCB01-0371) is a new oxazolidinone with cyclic amidrazone. |
|
| DC9949 |
DprE1-IN-2
Featured
|
DprE1-IN-2 is a potent DprE1 inhibitor. |
|
| DC8440 |
Erythromycin Cyclocarbonate
Featured
|
Erythromycin Cyclocarbonate, derivative of Erythromycin, inhibits protein synthesis of bacteria by binding to the 50S ribosome. |
|
| DC9350 |
Faropenem daloxate |
Faropenem daloxate is the first oral penem in a new class of beta-lactam antibiotics.
|
|
| DC1057 |
Fidaxomicin (Dificid)
Featured
|
Fidaxomicin, is an antibiotic that belongs to the class of macrocylic antibiotics. |
|
| DC8847 |
Finafloxacin (BAY35-3377)
Featured
|
Finafloxacin is a fluoroquinolone antimicrobial agent that exhibits optimum efficacy in slightly acidic environments. |
|
| DC8047 |
VRT-1353385 |
For the detailed information of VRT-1353385, the solubility of VRT-1353385 in water, the solubility of VRT-1353385 in DMSO, the solubility of VRT-1353385 in PBS buffer, the animal experiment (test) of VRT-1353385, the cell expriment (test) of VRT-1353385, the in vivo, in vitro and clinical trial test of VRT-1353385, the EC50, IC50,and affinity,of VRT-1353385, For the detailed information of VRT-1353385, the solubility of VRT-1353385 in water, the solubility of VRT-1353385 in DMSO, the solubility of VRT-1353385 in PBS buffer, the animal experiment (test) of VRT-1353385, the cell expriment (test) of VRT-1353385, the in vivo, in vitro and clinical trial test of VRT-1353385, the EC50, IC50,and affinity,of VRT-1353385, Please contact DC Chemicals.. |
|
| DC10307 |
Framycetin |
Framycetin (Fradiomycin B; Neomycin B) is an aminoglycoside antibiotic. It inhibits hammerhead ribozyme with a Ki of 13.5 μM. |
|
| DC8929 |
Garenoxacin |
Garenoxacin is a quinolone antibiotic for the treatment of Gram-positive and Gram-negative bacterial infections. |
|
| DC8893 |
Garenoxacin Mesylate hydrate |
Garenoxacin mesylate hydrate is a novel oral des-fluoro(6) quinolone with potent antimicrobial activity, against common respiratory pathogens, including resistant strains. |
|
| DC10161 |
Gepotidacin
Featured
|
Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor. |
|
| DC10567 |
KKL-10
Featured
|
KKL-10 is a small-molecule ribosome rescue inhibitor with broad-spectrum antimicrobial activity against bacteria. |
|
| DC8775 |
LED209 |
LED209 is a potent QseC inhibitor that blocks both norepinephrine- and epinephrine-triggered QseC-dependent virulence gene expression at 5 pM in vitro. |
|
| DC8928 |
Minocycline hydrochloride
Featured
|
Minocycline is a tetracycline antibiotic with neuroprotective, antiapoptotic, anti-inflammatory and antimicrobial effects. |
|
